Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03470051 · ClinicalTrials.gov registry record
Case Collection Study in the Evaluation of Doubling Time Rates in Non-Suspicious Breast Masses Using QT Ultrasound Technology
A clinical trial, sponsored by QT Ultrasound.
- Completed
- Registry status
- 27
- Enrollment target
NCT03470051: Completed study, sponsored by QT Ultrasound.
NCT03470051 is a clinical trial that has completed, run by QT Ultrasound. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03470051 has completed, sponsored by QT Ultrasound.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This is a prospective case collection study to collect cases for subsequent statistical studies and future reader studies.
Primary Outcome
The change in calculated mass doubling time using Quantitative Transmission Ultrasound (QT Ultrasound) from a minimum of two study timepoints will be measured and compared to mass histology.
Interventions
- DIAGNOSTIC_TEST QT Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-02-26 |
| Est. Completion | 2020-02-11 |
What the finished NCT03470051 record still lists
NCT03470051 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which QT Ultrasound is the first listed.
NCT03470051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03470051 about?
NCT03470051 is a clinical study titled "Case Collection Study in the Evaluation of Doubling Time Rates in Non-Suspicious Breast Masses Using QT Ultrasound Technology". This is a prospective case collection study to collect cases for subsequent statistical studies and future reader studies.
What is the current status of trial NCT03470051?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2018-02-26. Estimated completion is 2020-02-11.
What interventions are being tested in trial NCT03470051?
The interventions under investigation include: QT Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03470051?
This trial is sponsored by QT Ultrasound, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI